New COVID-19 Cases in 200s... KOSPI and KOSDAQ Up Over 1%

[Asia Economy Reporter Oh Ju-yeon] On the 25th, both the domestic KOSPI and KOSDAQ indices showed gains of over 1% following news that the number of new confirmed cases of the novel coronavirus infection (COVID-19) remained in the 200s for two consecutive days. The domestic stock market started higher, buoyed by the previous day’s U.S. stock market, but focused on the COVID-19 case numbers announced at 10 a.m.

Accordingly, the KOSPI’s rise rate fell from 0.96% to 0.48% during the session, but after the Central Disease Control Headquarters announced that the number of new COVID-19 cases as of midnight was 280, maintaining the 200s for two consecutive days, the index’s gains widened to over 1%.

As of 10:30 a.m., the KOSPI recorded 2354.17, up 1.04% from the previous trading day.

Among the top market capitalization stocks, Samsung Electronics (0.18%), SK Hynix (0.66%), LG Chem (1.00%), and Hyundai Motor (4.64%) rose, while Samsung Biologics (-0.49%), NAVER (-0.47%), Celltrion (-1.29%), and Kakao (-0.13%) declined.

By investor type, individuals net bought stocks worth 129.3 billion KRW, and foreigners also purchased 59 billion KRW worth. Institutions net sold stocks worth 196.7 billion KRW.

The KOSDAQ index rose 1.63% to 829.16 compared to the previous trading day.

Among the top market capitalization stocks, Celltrion Healthcare (-1.25%), Seegene (-1.24%), and Alteogen (-0.05%) declined, while HL Biopharma (0.44%) and Genexine (4.85%) rose.

This content was produced with the assistance of AI translation services.